The number of people with susceptibility test result for rifampicin in Uruguay
Uruguay: The number of people with susceptibility test result for rifampicin was 510 in 2021. ▬ Flat
Latest (2021)
510
Change on year
up 7.1%
World rank
78th
of 155 countries
All-time high
538
in 2019
All-time low
474
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Uruguay, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Uruguay is 510, measured in 2021.
The figure is up 7.1% on the previous year and up 7.6% over five years.
That places Uruguay 78th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Uruguay, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 474 | — |
| 2018 | 512 | +8.0% |
| 2019 | 538 | +5.1% |
| 2020 | 476 | -11.5% |
| 2021 | 510 | +7.1% |
Uruguay compared with similar countries
- Uruguay's 510 is above the median for high income countries, which is 142, 3.6× the median. (61 countries reporting)
- Uruguay's 510 is above the median for Latin America & Caribbean, which is 406.5, 1.3× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 508 | 474 | 538 | 3 |
| 2020s | 493 | 476 | 510 | 2 |
Countries ranked near Uruguay
More health data for Uruguay
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6727 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,631 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.79 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0241 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.84 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Uruguay?
- The number of people with susceptibility test result for rifampicin in Uruguay was 510 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Uruguay?
- The highest recorded value was 538 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Uruguay?
- The lowest recorded value was 474 in 2017.
- How does Uruguay rank for the number of people with susceptibility test result for rifampicin?
- Uruguay ranks 78th out of 155 countries with data for 2021.
- Where does this Uruguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).